MGAT2 inhibitors (Takeda)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameMGAT2 inhibitors (Takeda)
Drug Alias NameN-phenylindoline-5-sulfonamide derivatives
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action2-acylglycerol O-acyltransferase 2 inhibitors
Targets2-acylglycerol O-acyltransferase 2
Therapy Area/IndicationsObesityMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsObesityMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A